ドラッグデリバリーデバイスの世界市場、規模調査＆予測：投与経路別、用途別、エンドユーザー別、地域別分析、2023～2030年

ドラッグデリバリーデバイスは、新薬の発見と開発のプロセスで使用される技術的なツールや機器です。

これらの機器は、標的の同定や検証からリードの最適化や前臨床試験まで、創薬パイプラインのさまざまな段階で研究者や科学者を支援するように設計されています。ドラッグデリバリーデバイス市場が拡大している背景には、慢性疾患の有病率の増加、ドラッグデバイスの研究開発投資の増加、新薬の需要増加といった要因があります。

がん、心血管疾患、神経疾患などの慢性疾患の有病率が上昇しているため、ドラッグデリバリーデバイスの市場が拡大しています。これらの疾病に対処するための効果的な薬剤が必要とされており、これがドラッグデリバリーデバイスの需要を牽引しています。慢性疾患の負担増が革新的な薬剤の必要性を煽り、創薬研究への投資増と洗練されたドラッグデリバリーデバイスの開発につながっています。これらのデバイスは医薬品開発プロセスの効率と効果を高め、最終的には慢性疾患に対するより良い治療選択肢を提供することで患者に利益をもたらします。国際糖尿病連合は、2021年のインドの糖尿病患者数は7,419万4,700人と予想され、この数字は2030年までに9,297万3,700人に増加すると予測していると述べています。さらに、ロバート・ウッド・ジョンソン財団の報告によると、米国では2020年に1億5,700万人の慢性疾患患者が発生し、2030年には1億7,100万人に増加すると予想されています。さらに、国際がん研究機関（IARC）は、2021年には190万人であった新規症例が、2040年には全世界で約2,750万人になると推定しています。このように、世界中で慢性疾患の有病率が上昇していることが、市場成長の原動力となっています。さらに、戦略的イニシアチブの実施と新製品の創出の拡大が市場成長を促進しています。例えば、2021年3月、スタンフォード大学とノースカロライナ大学チャペルヒル校（UNC）の研究者は、3Dプリントワクチンパッチを作成し、従来のワクチン注射よりも優れた予防効果を提供するとしています。このような革新的なアイテムの創造は、薬物送達製品の使用を促進し、市場の拡大を促進しています。加えて、技術進歩のためのイニシアチブの高まり、個別化医療の発展、政府の有利な規制と政策が市場成長の機会を生み出しています。BLAは2023年第4四半期末までに提出される予定です。この製品の上市が成功すれば、患者に別の選択肢を提供できる可能性があります。しかし、ドラッグデリバリーデバイスのコストが高いことが、2023～2030年の予測期間を通じて市場の成長を阻害しています。

ドラッグデリバリーデバイスの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、主要な市場参入企業の存在、研究開発活動への投資の増加、様々な疾患の有病率の上昇、同地域における薬剤開発活動の高まりにより、2022年の市場を独占しました。一方、アジア太平洋は、慢性疾患の有病率の上昇、医療の進歩、ドラッグデリバリーデバイスの製造に対する政府の積極的な取り組み、同地域での製品上市の増加などの要因により、大きく成長すると予測されています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 ドラッグデリバリーデバイスの世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 ドラッグデリバリーデバイスの世界市場力学

• ドラッグデリバリーデバイス市場影響分析（2020～2030年）
  • 市場促進要因
    • 慢性疾患の増加
    • 研究開発投資の増加
    • 新薬に対する需要の増加
  • 市場の課題
    • ドラッグデリバリーのコスト高
  • 市場機会
    • 技術進歩に向けたイニシアチブの高まり
    • 個別化医療の進展
    • 有利な政府の規制と政策

第4章 ドラッグデリバリーデバイスの世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 ドラッグデリバリーデバイスの世界市場：投与経路別

• 市場スナップショット
• ドラッグデリバリーデバイスの世界市場：投与経路別、実績・ポテンシャル分析
• ドラッグデリバリーデバイスの世界市場：投与経路別、推定・予測、2020～2030年
• ドラッグデリバリーデバイス市場、サブセグメント分析
  • 注射薬
  • 局所薬
  • 点眼薬
  • その他

第6章 ドラッグデリバリーデバイスの世界市場：用途別

• 市場スナップショット
• ドラッグデリバリーデバイスの世界市場：用途別、実績・ポテンシャル分析
• ドラッグデリバリーデバイスの世界市場：用途別、推定・予測、2020～2030年
• ドラッグデリバリーデバイス市場、サブセグメント別分析
  • がん
  • 心血管
  • 糖尿病
  • 感染症
  • その他の用途

第7章 ドラッグデリバリーデバイスの世界市場：エンドユーザー別

• 市場スナップショット
• ドラッグデリバリーデバイスの世界市場：エンドユーザー別、実績・ポテンシャル分析
• ドラッグデリバリーデバイスの世界市場：エンドユーザー別、推定・予測、2020～2030年
• ドラッグデリバリー機器市場のサブセグメント分析
  • 病院
  • 外来手術センター
  • その他のエンドユーザー

第8章 ドラッグデリバリーデバイスの世界市場：地域別分析

• 主要国
• 主な新興国
• ドラッグデリバリーデバイス市場：地域別市場スナップショット
• 北米
  • 米国
    • 投与経路、推定・予測、2020～2030年
    • 用途、推定・予測、2020～2030年
    • エンドユーザー、推定・予測、2020～2030年
  • カナダ
• 欧州のドラッグデリバリーデバイス市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• アジア太平洋のドラッグデリバリーデバイス市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカのドラッグデリバリーデバイス市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他の中東およびアフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Pfizer Inc.
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
  • Novartis AG
  • F Hoffmann-La Roche Ltd
  • Johnson and Johnson Inc
  • Bayer AG
  • Becton, Dickinson and Company
  • Altaris
  • Holozymes Inc.（Antares Pharma Inc.）
  • GlaxoSmithKline PLC
  • Teva Pharmaceutical Industries Ltd

第10章 調査プロセス

• 調査プロセス
  • データ鉱業
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Drug Delivery Devices Market, report scope
• TABLE 2. Global Drug Delivery Devices Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3. Global Drug Delivery Devices Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
• TABLE 4. Global Drug Delivery Devices Market estimates & forecasts by Application 2020-2030 (USD Billion)
• TABLE 5. Global Drug Delivery Devices Market estimates & forecasts by End User 2020-2030 (USD Billion)
• TABLE 6. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Drug Delivery Devices Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. Global Drug Delivery Devices Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. U.S. Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17. U.S. Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18. U.S. Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19. Canada Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 20. Canada Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21. Canada Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22. UK Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 23. UK Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24. UK Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25. Germany Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 26. Germany Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27. Germany Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28. France Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 29. France Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30. France Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31. Italy Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 32. Italy Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33. Italy Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34. Spain Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 35. Spain Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36. Spain Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37. RoE Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 38. RoE Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39. RoE Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40. China Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 41. China Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42. China Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43. India Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 44. India Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45. India Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46. Japan Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 47. Japan Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48. Japan Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49. South Korea Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 50. South Korea Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51. South Korea Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52. Australia Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 53. Australia Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54. Australia Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55. RoAPAC Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57. RoAPAC Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58. Brazil Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 59. Brazil Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60. Brazil Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61. Mexico Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 62. Mexico Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63. Mexico Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64. RoLA Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 65. RoLA Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66. RoLA Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67. Saudi Arabia Drug Delivery Devices Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 68. South Africa Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69. RoMEA Drug Delivery Devices Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Drug Delivery Devices Market
• TABLE 71. List of primary sources, used in the study of global Drug Delivery Devices Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Drug Delivery Devices Market, research methodology
• FIG 2. Global Drug Delivery Devices Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Drug Delivery Devices Market, key trends 2022
• FIG 5. Global Drug Delivery Devices Market, growth prospects 2023-2030
• FIG 6. Global Drug Delivery Devices Market, porters 5 force model
• FIG 7. Global Drug Delivery Devices Market, pest analysis
• FIG 8. Global Drug Delivery Devices Market, value chain analysis
• FIG 9. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Drug Delivery Devices Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Drug Delivery Devices Market, regional snapshot 2020 & 2030
• FIG 15. North America Drug Delivery Devices Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Drug Delivery Devices Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Drug Delivery Devices Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Drug Delivery Devices Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Drug Delivery Devices Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Drug discovery devices are technological tools and instruments used in the process of discovering and developing new pharmaceutical drugs. These devices are designed to assist researchers and scientists in various stages of the drug discovery pipeline, from target identification and validation to lead optimization and preclinical testing. The Drug Delivery Devices market is expanding because of factors such as the increasing prevalence of chronic diseases, increasing research and development investment for drug devices, and increasing demand for novel drugs.

The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has created a substantial market for drug discovery devices. There is a need for effective drugs to address these diseases, which drives the demand for drug discovery devices. The rising burden of chronic diseases has fueled the need for innovative drugs, leading to increased investment in drug discovery research and the development of sophisticated drug discovery devices. These devices enhance the efficiency and effectiveness of the drug development process, ultimately benefiting patients by providing better treatment options for chronic diseases. The International Diabetes Federation stated that India has an anticipated 74,194.7 thousand cases of diabetes in 2021, and that figure is expected to increase to 92,973.7 thousand cases by 2030. Furthermore, the Robert Wood Johnson Foundation reports that there were 157 million cases of chronic illness in the United States in 2020, with an expected rise to 171 million cases by 2030. Furthermore, the International Agency for Research on Cancer (IARC), estimated that by the year 2040, there would be around 27.5 million new cases across the globe from 1.9 million new cases in the year 2021. Thus, the rising prevalence of the chronic disease across the globe is driving market growth. Moreover, the expansion of strategic initiative implementation and the creation of new products is fueling the market growth. For instance, in March 2021, researchers from Stanford University and the University of North Carolina at Chapel Hill (UNC) created a 3D-printed vaccine patch that they claim offers superior protection to a conventional vaccine shot. The creation of such innovative items is encouraging the use of medicine delivery products and fostering market expansion. In addition, growing initiatives for technological advancement, increasing development of personalized medicine, favorable government regulations and policies are creating opportunities to the market growth. The BLA is planned to be submitted by the end of Q4 2023. The successful launch of this product may provide patients with an alternative option. However, the high cost of drug delivery devices stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Drug Delivery Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising investment in research and development activities, rising prevalence of various diseases and rising drug development activities in the region. Whereas Asia Pacific is projected to have the significant growth owing to factors such as the rising prevalence of chronic diseases, rising healthcare advancement activities, favorable government initiatives for manufacturing drug delivery devices and rising product launches activities in the region.

Major market player included in this report are:

• Pfizer Inc.
• Novartis AG
• F Hoffmann-La Roche Ltd
• Johnson and Johnson Inc.
• Bayer AG
• Becton, Dickinson and Company
• Altaris
• Holozymes Inc. (Antares Pharma Inc.)
• GlaxoSmithKline PLC
• Teva Pharmaceutical Industries Ltd

Recent Developments in the Market:

• In June 2022, Gufic Biosciences Ltd. Introduced Dual Chamber Bags, a revolutionary drug delivery method, at competitive pricing. These dual-chamber IV bags include two chambers and are constructed of polypropylene (DEHP free), with an aluminium foil that could peeled off to store unstable medications that need to be reconstituted right before giving them to the patient.
• In February 2022, The US FDA approved Akeda's TAKHZYRO (lanadelumab-flyo) injectable as a single-dose prefilled syringe (PFS). Using this drug, HAE attacks are be avoided in both adults and children 12 years of age and older.

Global Drug Delivery Devices Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Route of Administration, Application, End User, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

• Injectable
• Topical
• Ocular
• Other Route of Administration

By Application:

• Cancer
• Cardiovascular
• Diabetes
• Infectious diseases
• Other Applications

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

By Region:

• North America
• U.S.
• Canada

• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

• Latin America
• Brazil
• Mexico

• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Drug Delivery Devices Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Drug Delivery Devices Market, by Route of Administration, 2020-2030 (USD Billion)
  • 1.2.3. Drug Delivery Devices Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4. Drug Delivery Devices Market, by End User, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Drug Delivery Devices Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Drug Delivery Devices Market Dynamics

• 3.1. Drug Delivery Devices Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevelance of chronic diseases
    • 3.1.1.2. Increasing research and development investment
    • 3.1.1.3. Increasing demand for novel drugs
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Drug Delivery Devices
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing initiatives for technological advancement
    • 3.1.3.2. Increasing development of personalized medicine
    • 3.1.3.3. Favourable government regulations and policies

Chapter 4. Global Drug Delivery Devices Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Drug Delivery Devices Market, by Route of Administration

• 5.1. Market Snapshot
• 5.2. Global Drug Delivery Devices Market by Route of Administration, Performance - Potential Analysis
• 5.3. Global Drug Delivery Devices Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
• 5.4. Drug Delivery Devices Market, Sub Segment Analysis
  • 5.4.1. Injectable
  • 5.4.2. Topical
  • 5.4.3. Ocular
  • 5.4.4. Other Route of Administration

Chapter 6. Global Drug Delivery Devices Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Drug Delivery Devices Market by Application, Performance - Potential Analysis
• 6.3. Global Drug Delivery Devices Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Drug Delivery Devices Market, Sub Segment Analysis
  • 6.4.1. Cancer
  • 6.4.2. Cardiovascular
  • 6.4.3. Diabetes
  • 6.4.4. Infectious diseases
  • 6.4.5. Other Applications

Chapter 7. Global Drug Delivery Devices Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Drug Delivery Devices Market by End User, Performance - Potential Analysis
• 7.3. Global Drug Delivery Devices Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 7.4. Drug Delivery Devices Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Other End Users

Chapter 8. Global Drug Delivery Devices Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Drug Delivery Devices Market, Regional Market Snapshot
• 8.4. North America Drug Delivery Devices Market
  • 8.4.1. U.S. Drug Delivery Devices Market
    • 8.4.1.1. Route of Administration breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Drug Delivery Devices Market
• 8.5. Europe Drug Delivery Devices Market Snapshot
  • 8.5.1. U.K. Drug Delivery Devices Market
  • 8.5.2. Germany Drug Delivery Devices Market
  • 8.5.3. France Drug Delivery Devices Market
  • 8.5.4. Spain Drug Delivery Devices Market
  • 8.5.5. Italy Drug Delivery Devices Market
  • 8.5.6. Rest of Europe Drug Delivery Devices Market
• 8.6. Asia-Pacific Drug Delivery Devices Market Snapshot
  • 8.6.1. China Drug Delivery Devices Market
  • 8.6.2. India Drug Delivery Devices Market
  • 8.6.3. Japan Drug Delivery Devices Market
  • 8.6.4. Australia Drug Delivery Devices Market
  • 8.6.5. South Korea Drug Delivery Devices Market
  • 8.6.6. Rest of Asia Pacific Drug Delivery Devices Market
• 8.7. Latin America Drug Delivery Devices Market Snapshot
  • 8.7.1. Brazil Drug Delivery Devices Market
  • 8.7.2. Mexico Drug Delivery Devices Market
• 8.8. Middle East & Africa Drug Delivery Devices Market
  • 8.8.1. Saudi Arabia Drug Delivery Devices Market
  • 8.8.2. South Africa Drug Delivery Devices Market
  • 8.8.3. Rest of Middle East & Africa Drug Delivery Devices Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Pfizer Inc.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Novartis AG
  • 9.3.3. F Hoffmann-La Roche Ltd
  • 9.3.4. Johnson and Johnson Inc
  • 9.3.5. Bayer AG
  • 9.3.6. Becton, Dickinson and Company
  • 9.3.7. Altaris
  • 9.3.8. Holozymes Inc. (Antares Pharma Inc.)
  • 9.3.9. GlaxoSmithKline PLC
  • 9.3.10. Teva Pharmaceutical Industries Ltd

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption